Intravenous Immunoglobulin Therapy in Adult Patients with Chronic Idiopathic Cardiomyopathy and Cardiac Parvovirus B19 persistence

ConclusionIVIg therapy does not significantly improve cardiac systolic function or functional capacity beyond standard medical therapy in patients with idiopathic chronic DCM and cardiac B19V persistence.

Source: European Journal of Heart Failure - December 21, 2020 Category: Cardiology Authors: Mark R. Hazebroek, Michiel T.H.M. Henkens, Anne G. Raafs, Job A.J. Verdonschot, Jort J. Merken, Robert M. Dennert, Casper Eurlings, Myrurgia A. Abdul Hamid, Petra F.G. Wolffs, Bjorn Winkens, Hans ‐Peter Brunner‐La Rocca, Christian Knacksted Tags: Research Article Source Type: research